Clone: | 9F1 |
|
Host: | Mouse |
|
Isotype: | IgG1 |
|
Immunogen: | Synthetic peptide corresponding to aa 1-42 amyloid β A4. |
|
UniProt ID: | P05067 |
|
Species reactivity: | Human
|
|
Crossreactivity: | Cross-reacts with APP. |
|
Applications: | ELISA, ICC, WB
|
|
Recommended Dilutions/Conditions: | ELISA (0.05µg/ml) Immunocytochemistry (0.1-1.0µg/ml) Western Blot (1µg/ml) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Application Notes: | Detects a band of ~4kDa by Western blot. |
|
Purity Detail: | Thiophilic adsorption and size exclusion chromatography purified. |
|
Formulation: | Lyophilized from 1ml of 2x PBS containing 0.09% sodium azide, PEG, and sucrose. |
|
Reconstitution: | Reconstitute with 1ml water (15 minutes at room temperature). |
|
Use/Stability: | Stable at -80°C up to 1 year, at 4°C up to 3 months. |
|
Shipping: | Shipped on Blue Ice |
|
Long Term Storage: | -20°C |
|
Scientific Background: | The beta-amyloid peptide (beta A4), proteolytically released from the amyloid precursor protein (APP), provides the principal component of senile plaques in Alzheimer's disease. Cleavage of APP by alpha-secretase or alternatively by beta-secretase leads to generation and extracellular release of soluble APP peptides, S-APP-alpha and S-APP-beta, respectively, and the retention of corresponding membrane-anchored C-terminal fragments, C83 and C99. Subsequent processing of C83 by gamma-secretase yields P3 peptides. This is the major secretory pathway and is nonamyloidogenic. Alternatively, presenilin/ nicastrin-mediated gamma-secretase processing of C99 releases the amyloid beta proteins, amyloid-beta 40 (Abeta40) and amyloid-beta 42 (Abeta42), major components of amyloid plaques, and the cytotoxic C-terminal fragments, gamma-CTF(50), gamma-CTF(57) and gamma-CTF(59). |
|
Regulatory Status: | RUO - Research Use Only |
|